Machine-learning-based prediction of acute and late-onset skin reactions after neoadjuvant chemoradiotherapy for rectal cancer: a retrospective cohort study
Overall model performance indicated moderate discriminative ability, with AUC values below 0.75 across all models, which suggest potential utility for risk stratification and further external validation in larger prospective cohorts is required prior to clinical application.
Abstract
To develop and validate machine learning models for predicting acute and late radiation-induced skin reactions in patients with locally advanced rectal cancer who received neoadjuvant chemoradiotherapy. This retrospective analysis included 358 patients with locally advanced rectal cancer. Multimodal preprocessing data including clinical, anatomical, hematological and dosimetric data were collected. The univariate analysis was only used to describe the baseline correlation and was not used as the basis for feature selection. After evaluating multicollinearity by Spearman correlation analysis and VIF, the six algorithms were trained using a stratified 70/30 split and five-fold cross-validation of the training set. The independent test set was retained for the final evaluation. The performance metrics included AUC, F1 score, accuracy, sensitivity, specificity, balanced accuracy and calibration indicators. In the test cohort, the best-performing model for acute radiation-induced skin reactions was XGBoost, achieving an AUC of 0.617 (95% CI 0.510–0.719). For late reactions, LightGBM achieved the highest discriminative performance with an AUC of 0.707 (95% CI 0.563–0.845). Key clinical and dosimetric variables associated with skin toxicity included tumor distance from the anal verge, age, prealbumin level, and V5000cGy dose parameters. Although collinearity diagnostics revealed substantial collinearity, particularly for the late-onset endpoint, tree-based models maintained stable predictive performance across validation folds. Overall model performance indicated moderate discriminative ability, with AUC values below 0.75 across all models. Machine learning models integrating multimodal clinical and dosimetric features demonstrated moderate performance in predicting radiation-induced skin toxicity in rectal cancer patients. These findings suggest potential utility for risk stratification; however, further external validation in larger prospective cohorts is required prior to clinical application.
PURPOSE
To develop and internally evaluate a compact multimodal machine learning model for predicting acute genitourinary (GU) toxicity after prostate cancer radiotherapy and to assess the effect of validation design on estimated performance.
METHODS
A retrospective cohort of 92 patients was analyzed, including 84 tr...
A. Smyslov, O. Stakhova, E. S. Sukhikh· Physica medica (Testo stampa...· 0 citations
Acute radiation esophagitis (ARE) is a clinically relevant toxicity occurring in patients with breast cancer receiving post-operative regional nodal irradiation. The present study aimed to develop and evaluate an interpretable machine-learning (ML) model for grade ≥2 ARE. A total of 324 patients were allocated by outco...
Background: Radiotherapy-induced lymphopenia (RIL) is a clinically relevant hematologic toxicity in patients with breast cancer, yet early risk assessment before radiotherapy remains challenging because existing approaches often rely on dosimetric parameters or hematologic changes observed during treatment. This study...
Lei Ding, Hao Qiu, Miao Wang et al.· International Journal of Gen...· 0 citations
Breast cancer patients receiving neoadjuvant treatment may benefit from a presurgical assessment of complete response to avoid unnecessary surgeries. We aimed to develop a machine learning model that predicts pathological complete response (pCR) based on results from different image modalities as well as tumor and pati...
Eva Reisig, Lie Cai, Maria Müller et al.· BMC Cancer· 0 citations
Background Radioiodine-refractory differentiated thyroid cancer (RAIR-DTC) poses a major therapeutic challenge, with loss of radioiodine avidity, limited treatment options, and worse outcomes. Current risk stratification systems were not designed to predict RAIR transformation before clinical refractoriness. Methods Th...
Gong-Xun Tan, Yue Zhang, Zhen-Wei Mao et al.· Frontiers in Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.